Brain Tumors

    The precision of the CyberKnife System maximizes radiation delivered to the target.

An effective, less disruptive treatment option

The precision of the CyberKnife System maximizes radiation delivered to the target — while minimizing the dose to surrounding healthy tissues. The result is a highly effective treatment that eliminates many of the inconveniences of other treatments — and significantly reduces the risk of the side effects that too often disrupt the lives of patients during and after treatment.

CYBERKNIFE VS. SURGERY

The CyberKnife System offers many of the same benefits of precise surgical intervention. But CyberKnife radiosurgery is an outpatient procedure that does not require incisions or general anesthesia. Most patients will not require hospitalization or a long recovery period.

CYBERKNIFE VS. CONVENTIONAL WHOLE-BRAIN RADIATION

Instead of delivering radiation to all brain tissues, CyberKnife radiosurgery targets the tumor(s) with sub-millimeter precision, protecting healthy brain tissues and reducing the risk of common cognitive side effects of whole-brain radiation. In addition, CyberKnife radiosurgery may be completed in as little as 1-5 sessions within 1-2 weeks, compared with 10-15 sessions over 2-3 weeks with conventional whole-brain radiation.

CYBERKNIFE VS. FRAME-BASED GAMMA KNIFE SRS

Compared with single-session radiosurgery with the frame-based Gamma Knife, treatment with the CyberKnife System can be spread out over 1-5 sessions, which may result in fewer side effects1.


Brain Cancer


Sub-millimeters matter. Choose CyberKnife precision.

When it comes to the delicate and complex tissues and structures of the brain, precision matters. The CyberKnife System gives you a proven, non-surgical option for treating your brain tumor while helping to protect your quality of life, including your cognitive abilities, such as remembering things and concentrating, that may be negatively impacted with whole brain radiotherapy.

Delivering stereotactic radiosurgery (SRS) treatments with unrivaled, sub-millimeter accuracy, the CyberKnife provides excellent clinical outcomes in treating a wide range of brain tumors — in fewer visits and with a significantly lower risk of the most common side effects of traditional surgery and radiotherapy treatments.

Key CyberKnife treatment benefits

  • Non-surgical and non-invasive
  • No head frame is required
  • Good cancer control
  • Reduced incidence of common cognitive side effects
  • Treatments may be completed in as little as 1-5 sessions within 1-2 weeks
  • Most patients can continue normal activity throughout treatment
  • Typically does not require interruption of chemotherapy cycles or immunotherapy treatments
  • Patients previously treated with whole brain radiotherapy may be candidates for CyberKnife SRS treatment
  • Patients previously treated with SRS may be candidates for CyberKnife SRS in other areas of the brain

Side Effects

Treatment with the CyberKnife System is well-tolerated with a low risk of toxicity. Side effects associated with CyberKnife treatment are usually mild and temporary. As with any radiation treatment, side effects can also be severe in some patients and lead to permanent injury or even death. Discuss your specific case with your physician/s to fully understand the potential risks associated with your treatment.